The BRCA1 exon 13 duplication in the Swedish population

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Familial Cancer

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10689-004-7023-2PMID 15951973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families.

  2003cited by this paper
• Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breast‐ovarian cancer family

  2003cited by this paper
• Rapid detection of novel BRCA1 rearrangements in high‐risk breast‐ovarian cancer families using multiplex PCR of short fluorescent fragments

  2002cited by this paper
• Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families

  2002cited by this paper
• Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1:ψBRCA1 recombination

  2002cited by this paper
• Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

  2002cited by this paper
• Identification of a large rearrangement of theBRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing

  2001cited by this paper
• The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.

  2000cited by this paper
• An Alu‐mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10

  2000cited by this paper
• Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.

  2000cited by this paper
• Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer

  2000cited by this paper
• Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions.

  1999cited by this paper
• An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation?

  1999cited by this paper
• BRCAl Screening in Patients with a Family History of Breast or Ovarian Cancer

  1999cited by this paper
• Screening for GermLine Rearrangements and Regulatory Mutations in BRCA 1 Led to the Identification of Four New Deletions 1

  1999cited by this paper
• BRCA2 germline mutations in Swedish breast cancer families

  1998cited by this paper
• BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

  1997cited by this paper
• A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.

  1997cited by this paper
• Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family.

  1997cited by this paper
• Computer programs for multilocus haplotyping of general pedigrees.

  1995cited by this paper

• A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31

  2023cites this paper
• Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland

  2022cites this paper
• Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa

  2021cites this paper
• To Build or To Break: The Dual Impact of Interspersed Transposable Elements in Cancer

  2021cites this paper
• The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer

  2020cites this paper
• Complex Characterization of Germline Large Genomic Rearrangements of the BRCA1 and BRCA2 Genes in High-Risk Breast Cancer Patients—Novel Variants from a Large National Center

  2020cites this paper
• Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.

  2017cites this paper
• Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing

  2014cites this paper
• Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.

  2011cites this paper
• Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• Founder BRCA 1 / 2 mutations in the Europe : implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families

  2009cites this paper
• Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer

  2007cites this paper
• FAMILY HISTORY AND BREAST CANCER SUSCEPTIBILITY

  2006cites this paper
• Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

  2006cites this paper